The German etanercept registry for treatment of juvenile idiopathic arthritis

Objective: To describe a registry set up to monitor children treated with etanercept in Germany and Austria. Methods: Giannini's criteria, duration of morning stiffness, number of swollen, tender and contracted joints, adverse events, and reasons for discontinuation were assessed. Results: 322...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Horneff, G, Schmeling, H, Biedermann, T, Foeldvari, I, Ganser, G, Girschick, H, Hospach, T, Huppertz, H, Keitzer, R, Kuster, R, Michels, H, Moebius, D, Rogalski, B, Thon, A, t for
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2004
Aiheet:
Extended Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1754849/
https://ncbi.nlm.nih.gov/pubmed/15115709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.014886
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia